Literature DB >> 2446901

Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes.

C G Begley1, D Metcalf, N A Nicola.   

Abstract

The binding of purified 125I-labeled murine granulocyte colony stimulating factor (125I-G-CSF) to normal and leukemic human cells was examined. Normal neutrophils and their precursors demonstrated specific labeling with 125I-G-CSF, whereas eosinophils, lymphocytes, and erythroid cells did not. Normal human promyelocytes demonstrated the highest binding among hemopoietic cells. Human myeloid leukemic cells also demonstrated consistent specific labeling with 125I-G-CSF. Normal promyelocytes and chronic myeloid leukemia promyelocytes demonstrated only transient clonal proliferation in vitro when stimulated by G-CSF, but this was not always the case with acute promyelocytic leukemic cells. The qualitative responsiveness of normal and leukemic cells to G-CSF was very similar despite heterogeneity in receptor numbers on individual cells. A subset of acute promyelocytic leukemic cells appeared unresponsive to stimulation by GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2446901

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

Review 1.  Recombinant methionyl granulocyte colony-stimulating factor (filgrastim): a new dimension in immunotherapy.

Authors:  G Schwab; T Hecht
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

2.  Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates.

Authors:  A Heyll; C Aul; F Gogolin; M Thomas; M Arning; A Gehrt; U Hadding
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

3.  G-CSF receptor-mediated up-regulation of c-fos but not c-raf mRNA expression in myeloid cells.

Authors:  R V Deshpande; M A Moore
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

4.  Hematopoietic growth factor receptors.

Authors:  J H Shieh; M A Moore
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

5.  Neutrophil elastase downmodulates native G-CSFR expression and granulocyte-macrophage colony formation.

Authors:  Melissa G Piper; Pam R Massullo; Megan Loveland; Lawrence J Druhan; Tamila L Kindwall-Keller; Jing Ai; Alexander Copelan; Belinda R Avalos
Journal:  J Inflamm (Lond)       Date:  2010-01-21       Impact factor: 4.981

6.  LRG-accelerated differentiation defines unique G-CSFR signaling pathways downstream of PU.1 and C/EBPepsilon that modulate neutrophil activation.

Authors:  Jing Ai; Lawrence J Druhan; Melissa G Hunter; Megan J Loveland; Belinda R Avalos
Journal:  J Leukoc Biol       Date:  2008-02-13       Impact factor: 4.962

7.  Role of the proteasome in modulating native G-CSFR expression.

Authors:  Tamila L Kindwall-Keller; Lawrence J Druhan; Jing Ai; Melissa G Hunter; Pam Massullo; Megan Loveland; Belinda R Avalos
Journal:  Cytokine       Date:  2008-06-12       Impact factor: 3.861

8.  Identification of a common signal associated with cellular proliferation stimulated by four haemopoietic growth factors in a highly enriched population of granulocyte/macrophage colony-forming cells.

Authors:  N Cook; T M Dexter; B I Lord; E J Cragoe; A D Whetton
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

9.  Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains.

Authors:  A Larsen; T Davis; B M Curtis; S Gimpel; J E Sims; D Cosman; L Park; E Sorensen; C J March; C A Smith
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  G-CSFR ubiquitination critically regulates myeloid cell survival and proliferation.

Authors:  Jing Ai; Lawrence J Druhan; Megan J Loveland; Belinda R Avalos
Journal:  PLoS One       Date:  2008-10-16       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.